poisar

Stock

Artivion, Inc. AORT

$25.35+1.38%

Overview

AORT market data

Price History

AORT price chart

Valuation & Profitability

Alpha Vantage
P/E (TTM)
91.08
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
41.32
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
$0.25
Diluted earnings per share over the trailing twelve months.
Beta
1.40
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
2.6%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$19.16 – $48.25
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
$42.88
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · source Alpha Vantage OVERVIEW · market cap $1.1B · P/B 2.74 · P/S 2.41.

Company news

4 captured
Needham Reiterates Buy on Artivion, Maintains $44 Price TargetBenzinga · Jul 20, 2026, 10:12 AM
Artivion Seeks To Tap $150 Million US Market Opportunity With FDA ApprovalBenzinga · Jun 29, 2026, 5:45 PM
Artivion Says FDA Approves Premarket Approval Application For AMDS Hybrid ProsthesisBenzinga · Jun 29, 2026, 11:20 AM
8-K filing — ARTIVION, INC. (AORT)SEC EDGAR · May 18, 2026, 11:06 AM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock